AGBA Acquisition Vermögensrendite
Was ist das Vermögensrendite von AGBA Acquisition?
Vermögensrendite von AGBA Acquisition Limited ist -61.39%
Was ist die Definition von Vermögensrendite?
Die Vermögensrendite gibt an, wie rentabel die Vermögenswerte eines Unternehmens bei der Erzielung von Einnahmen sind. Sie wird berechnet, indem das Nettoeinkommen durch die durchschnittliche Bilanzsumme geteilt wird.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Vermögensrendite von Unternehmen in Finance Sektor auf NASDAQ im Vergleich zu AGBA Acquisition
Was macht AGBA Acquisition?
AGBA Acquisition Limited does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare, education, entertainment, and financial services sectors in China. The company was incorporated in 2018 and is based in Tsim Sha Tsui, Hong Kong.
Unternehmen mit vermögensrendite ähnlich AGBA Acquisition
- Rokmaster Resources hat Vermögensrendite von -61.63%
- Keytone Dairy hat Vermögensrendite von -61.60%
- Minaean SP Construction hat Vermögensrendite von -61.54%
- Clene Nanomedicine hat Vermögensrendite von -61.47%
- Naturally Splendid Enterprises hat Vermögensrendite von -61.47%
- DropCar hat Vermögensrendite von -61.42%
- AGBA Acquisition hat Vermögensrendite von -61.39%
- PolyPid hat Vermögensrendite von -61.37%
- AML3D hat Vermögensrendite von -61.33%
- Wize Pharma hat Vermögensrendite von -61.32%
- Avadel Pharmaceuticals plc hat Vermögensrendite von -61.29%
- EVE Investments hat Vermögensrendite von -61.26%
- Benitec Biopharma Inc hat Vermögensrendite von -61.24%